Chia Tai Tianqing Pharmaceutical - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsChia Tai Tianqing Pharmaceutical

Chia Tai Tianqing Pharmaceutical

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Fosaprepitant dimeglumine	Fosaprepitant dimeglumine	2021-03-03		—
Fulvestrant	Fulvestrant	2020-02-07	2034	Breast neoplasms

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

healthy volunteers/patients

,

pharmacokinetics

,

,

non-hodgkin lymphoma

,

acrocephalosyndactylia

,

endometrioid carcinoma

,

peritoneal neoplasms

,

hereditary breast and ovarian cancer syndrome

,

malignant mesothelioma

,

,

pharmacological phenomena

,

,

,

,

digestive system neoplasms

,

urinary bladder neoplasms

,

neuroendocrine tumors

,

islet cell adenoma

,

urogenital neoplasms

,

female genital neoplasms

,

esophageal neoplasms

,

colonic neoplasms

,

spinocerebellar degenerations

,

,

inguinal hernia

,

,

,

ovarian neoplasms

,

non-small-cell lung carcinoma

,

endometrial neoplasms

,

prostatic neoplasms

,

ovarian epithelial carcinoma

,

colorectal neoplasms

,

squamous cell carcinoma of head and neck

,

uterine cervical neoplasms

,

,

,

castration-resistant prostatic neoplasms

,

fallopian tube neoplasms

,

hereditary sensory and autonomic neuropathies

,

breast diseases

,

stomach neoplasms

,

small cell lung carcinoma

,

ductal carcinoma

,

,

pancreatic neoplasms

,

carcinoma in situ

,

head and neck neoplasms

,

neoplasms by site

,

urologic neoplasms

,

uterine neoplasms

,

brain neoplasms

,

circulating neoplastic cells

,

intraductal carcinoma noninfiltrating

,

,

,

transitional cell carcinoma

,

squamous cell carcinoma

,

,

biliary tract neoplasms

,

adenocarcinoma of lung

,

serous cystadenocarcinoma

,

,

,

sex cord-gonadal stromal tumors

,

endometrial stromal sarcoma

,

,

,

pulmonary arterial hypertension

,

familial primary pulmonary hypertension

,

systemic lupus erythematosus

,

precocious puberty

,

polyostotic fibrous dysplasia

,

inborn genetic diseases

,

,

insulin resistance

,

,

hyperinsulinism

,

molecular targeted therapy

,

large b-cell lymphoma diffuse

,

salivary gland neoplasms

,

,

myxoid liposarcoma

,

esophageal squamous cell carcinoma

,

squamous cell neoplasms

,

,

,

,

male breast neoplasms

,

invasive hydatidiform mole

,

disease progression

,

lobular carcinoma

,

ductal carcinoma breast

,

neoadjuvant therapy

,

progression-free survival

,

cholangiocarcinoma

,

unilateral breast neoplasms

,

breast neoplasms

,

,

triple negative breast neoplasms

,

neoplasm metastasis

,

multiple endocrine neoplasia type 1

,

eye abnormalities

,

,

cutaneous malignant melanoma

,

abdominal neoplasms

,

retroperitoneal neoplasms

,

renal insufficiency

,

ovarian neoplasms

,

,

ovarian epithelial carcinoma

,

prostatic neoplasms

,

,

inflammatory breast neoplasms

,

,

head and neck neoplasms

,

,

colorectal neoplasms

,

urethral neoplasms

,

ureteral neoplasms

,

renal cell carcinoma

,

fallopian tube neoplasms

,

,

rhabdomyosarcoma

,

pancreatic neoplasms

,

pelvic neoplasms

,

colonic neoplasms

,

,

circulating neoplastic cells

,

,

soft tissue neoplasms

,

malignant fibrous histiocytoma

,

residual neoplasm

,

solitary fibrous tumors

,

hemangiopericytoma

,

fibrous tissue neoplasms

,

hemangiosarcoma

,

epithelioid hemangioendothelioma

,

,

uterine cervical neoplasms

,

salivary gland neoplasms

,

castration-resistant prostatic neoplasms

,

uterine neoplasms

,

,

mullerian mixed tumor

,

hepatocellular carcinoma

,

,

triple negative breast neoplasms

,

,

,

neoplasm metastasis

,

,

,

non-small-cell lung carcinoma

,

brain neoplasms

,

urologic neoplasms

,

urinary bladder neoplasms

,

transitional cell carcinoma

,

hereditary breast and ovarian cancer syndrome

,

,

,

invasive hydatidiform mole

,

meningeal neoplasms

,

meningeal carcinomatosis

,

,

breast neoplasms

,

male breast neoplasms

,

neurotoxicity syndromes

,

drug-related side effects and adverse reactions

,

peripheral nervous system diseases

,

alopecia areata

,

,

treatment outcome

,

gastrointestinal neoplasms

Eribulin mesylate

breast neoplasms

,

breast neoplasms

,

esophageal neoplasms

,

esophageal squamous cell carcinoma

,

Mycophenolate sodium

healthy volunteers/patients

,

drug-related side effects and adverse reactions

,

adenocarcinoma of lung

,

meningeal carcinomatosis

,

gastrointestinal stromal tumors

,

cholangiocarcinoma

,

pancreatic neoplasms

,

t-cell lymphoma peripheral

,

t-cell lymphoma

,

biliary tract neoplasms

,

uterine cervical neoplasms

,

,

healthy volunteers/patients

,

large b-cell lymphoma diffuse

,

,

chemoradiotherapy

,

colonic neoplasms

,

b-cell lymphoma

,

neuroendocrine carcinoma

,

,

molecular targeted therapy

,

thoracic neoplasms

,

ovarian neoplasms

,

neuroendocrine tumors

,

brain neoplasms

,

,

,

multiple primary neoplasms

,

t-cell lymphoma cutaneous

,

microsatellite instability

,

mouth neoplasms

,

malignant mesothelioma

,

,

,

residual neoplasm

,

gastrointestinal neoplasms

,

digestive system neoplasms

,

,

clear cell adenocarcinoma

,

adenomyoepithelioma

,

,

microsatellite repeats

,

immunoblastic lymphadenopathy

,

adoptive immunotherapy

,

respiratory tract diseases

,

,

precancerous conditions

,

aortic dissection

,

perioperative period

,

salivary gland neoplasms

,

unknown primary neoplasms

,

malignant fibrous histiocytoma

,

disorders of sex development

,

hemangiosarcoma

,

,

,

oligodendroglioma

,

,

cutaneous malignant melanoma

,

appendiceal neoplasms

,

gallbladder neoplasms

,

lymphatic metastasis

,

head and neck neoplasms

,

airway obstruction

,

intensity-modulated radiotherapy

,

maintenance chemotherapy

,

follicular lymphoma

,

mantle-cell lymphoma

,

central nervous system neoplasms

,

vaginal neoplasms

,

vulvar neoplasms

,

spinocerebellar degenerations

,

,

acquired immunodeficiency syndrome

,

opportunistic infections

,

hepatocellular carcinoma

,

,

liver neoplasms

,

colorectal neoplasms

,

,

squamous cell carcinoma

,

esophageal squamous cell carcinoma

,

,

neoplasm metastasis

,

rectal neoplasms

,

esophageal neoplasms

,

nasopharyngeal carcinoma

,

nasopharyngeal neoplasms

,

,

squamous cell carcinoma of head and neck

,

small cell lung carcinoma

,

neoadjuvant therapy

,

,

renal cell carcinoma

,

extranodal nk-t-cell lymphoma

,

,

endometrial neoplasms

,

,

squamous cell neoplasms

,

,

gastrointestinal diseases

,

esophageal diseases

,

,

radiation pneumonitis

,

adjuvant chemotherapy

,

adjuvant radiotherapy

,

,

epstein-barr virus infections

,

non-small-cell lung carcinoma

,

stomach neoplasms

,

,

,

,

breast neoplasms

,

hodgkin disease

,

triple negative breast neoplasms

,

thyroid neoplasms

,

thyroid diseases

,

,

chronic hepatitis b

,

catheter ablation

,

female genital neoplasms

,

abdominal neoplasms

,

,

venous thrombosis

,

hemophagocytic lymphohistiocytosis

,

,

,

,

gastrointestinal microbiome

,

acute kidney injury

,

tumor microenvironment

,

,

,

chronic hepatitis

,

endometrioid carcinoma

,

,

progression-free survival

,

,

,

esophageal squamous cell carcinoma

,

squamous cell carcinoma

,

neoplasm metastasis

,

,

renal cell carcinoma

,

cholangiocarcinoma

,

pancreatic neoplasms

,

small cell lung carcinoma

,

esophageal neoplasms

,

endometrial neoplasms

,

,

triple negative breast neoplasms

,

,

biliary tract neoplasms

,

urinary bladder neoplasms

,

squamous cell carcinoma of head and neck

,

breast neoplasms

,

squamous cell neoplasms

,

microsatellite instability

,

brain neoplasms

,

endometrioid carcinoma

,

,

,

malignant mesothelioma

,

,

ductal carcinoma

,

urologic neoplasms

,

kidney neoplasms

,

,

t-cell lymphoma

,

t-cell lymphoma peripheral

,

,

portal hypertension

,

vulvar neoplasms

,

invasive hydatidiform mole

,

bile duct neoplasms

,

salivary gland neoplasms

,

transitional cell carcinoma

,

,

,

recreational drug use

,

local neoplasm recurrence

,

pancreatic ductal carcinoma

,

meningeal carcinomatosis

,

,

hepatocellular carcinoma

,

uterine cervical neoplasms

,

non-small-cell lung carcinoma

,

colorectal neoplasms

,

liver neoplasms

,

,

stomach neoplasms

,

,

,

nasopharyngeal carcinoma

,

nasopharyngeal neoplasms

,

neoadjuvant therapy

,

healthy volunteers/patients

,

ovarian neoplasms

,

ovarian epithelial carcinoma

,

rectal neoplasms

,

,

,

adjuvant chemotherapy

,

,

small cell carcinoma

,

neuroendocrine carcinoma

healthy volunteers/patients

,

pharmacokinetics

,

,

type 2 diabetes mellitus

,

diabetes mellitus

,

systemic scleroderma

,

diffuse scleroderma

,

,

non-alcoholic fatty liver disease

,

,

squamous cell carcinoma of head and neck

,

,

non-small-cell lung carcinoma

,

neoplasm metastasis

,

,

,

squamous cell carcinoma

,

colorectal neoplasms

,

triple negative breast neoplasms

,

,

biliary tract neoplasms

,

tertiary lymphoid structures

Efbemalenograstim alfa

non-small-cell lung carcinoma

,

,

febrile neutropenia

,

colorectal neoplasms

,

pancreatic neoplasms

,

ovarian neoplasms

,

uterine cervical neoplasms

,

,

breast neoplasms

,

1

2

3

4

5

6

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use